FIELD: medicine.
SUBSTANCE: 30-60 minutes after the following fraction of radical irradiation on the 1st, 3rd and 5th day of each week for the whole period of irradiation, the preparation Molixan® 60 mg (2 ml) is introduced intramuscularly to the patient.
EFFECT: higher efficacy and safety of the chemotherapy ensured by relieving the manifestations of oral mucositis.
4 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATING LOCALLY ADVANCED OROPHARYNGEAL CANCER | 2009 |
|
RU2401139C1 |
METHOD FOR TREATMENT OF LOCALLY ADVANCED OROPHARYNGEAL CANCER | 2007 |
|
RU2347591C1 |
METHOD FOR OROPHARYNGEAL CANCER CHEMORADIATION | 2016 |
|
RU2632542C1 |
METHOD OF TREATING SQUAMOUS ORAL CANCER AND PHARYNX IN COMBINATION WITH RADIATION AND DRUG EXPOSURE | 2019 |
|
RU2705109C2 |
METHOD FOR TREATING OROPHARYNGEAL SQUAMOUS CELL CARCINOMA | 2018 |
|
RU2689875C2 |
METHOD OF CHEMORADIATION THERAPY OF LOW-LOCATED TUMOURS OF RECTUM AND ANAL CANAL | 2009 |
|
RU2400268C1 |
METHOD FOR TREATMENT OF SQUAMOUS CELL P-16 POSITIVE OROPHARYNGEAL CANCER | 2020 |
|
RU2751818C2 |
METHOD FOR TREATING PATIENTS WITH TOPICALLY METASTASING PHARYNGEAL CANCER | 2005 |
|
RU2289364C1 |
METHOD OF TREATING OROPHARYNGEAL SQUAMOUS CELL CARCINOMA | 2010 |
|
RU2429032C1 |
METHOD OF COMPLEX THERAPY OF PATIENTS WITH SQUAMOUS CELL CARCINOMA OF ORAL MUCOSA | 2007 |
|
RU2332227C1 |
Authors
Dates
2014-06-10—Published
2012-11-21—Filed